NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Sticta Biologicals

Sticta Biologicals

Private
SantiagoHealthcare & Life Scienceshttps://www.sticta.com/

Last Round

Grant

Oct 28, 2024

Total Funding Raised

$140,000

Company Overview

Sticta Biologicals is a biotechnology company that develops a microbial platform using precision fermentation to produce recombinant proteins and growth factors for the cultivated meat and biopharmaceutical industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

precision fermentationcultivated meatcell culture mediarecombinant proteinslab-grown meatgrowth factorssynthetic biologybioprocess optimizationanimal-free serummetabolic modelingalternative proteinbiotech ingredientscell culture supplementbioinformaticsclean meat

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sticta Biologicals Comparables

Compare Sticta Biologicals with similar companies based on industry and business-model similarity.

Sticta Biologicals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Multus Biotechnology
88%
Immobazyme
84%
Defined Bioscience
84%

Sticta Biologicals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 28, 2024
AcceleratorApr 1, 2023

Key People

Founding team and executive leadership

Vicente Cataldo von Bohlen

Co-founder & Chief Scientific Officer (CSO)

Founding Team

Andres Ariztia

Chief Executive Officer, Co-Founder

Founding Team

Eduardo Agosin

Chief Executive Officer

Executive Team

Sticta Biologicals Investors

Notable investors and investment history

Sticta Biologicals investors
InvestorRounds
ProVeg IncubatorAccelerator

Sticta Biologicals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sticta Biologicals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sticta Biologicals's valuation, stock price, and market status.

Firmographic Details

HeadquartersSantiago
Employee Range13
Year Founded2021
Last FundingOct 28, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.